02179.HK
Jiangsu Recbio Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 5.00
+0.00%Margins
Gross margin
-55.0%
EBITDA margin
-2431.0%
EBIT margin
-2897.9%
Net margin
-2937.2%
FCF margin
-2414.7%
-226.5%
Return on equity
-70.7%
Return on assets
-95.0%
Return on invested capital
0.02x
Asset turnover
-HKD 851.2M
Cash from operations
HKD 0.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026